Emergence of Anti-CD20 Therapies for Individuals With Multiple Sclerosis Planning Pregnancy

Kristen M Krysko^{1

2

3}

Affiliations

¹ BARLO MS Centre, Division of Neurology, Department of Medicine, St Michael's Hospital, Toronto, Ontario, Canada.
² Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
³ Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada.

Kristen M Krysko. JAMA Neurol. 2025.

. 2025 Oct 1;82(10):983-984.

doi: 10.1001/jamaneurol.2025.2559.

Kristen M Krysko^{1

2

3}

¹ BARLO MS Centre, Division of Neurology, Department of Medicine, St Michael's Hospital, Toronto, Ontario, Canada.
² Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
³ Li Ka Shing Knowledge Institute, Toronto, Ontario, Canada.

No abstract available

Comment in

Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.
Gavoille A, Rollot F, Casey R, Mathey G, Le Page E, Ciron J, De Sèze J, Ruet A, Maillart E, Labauge P, Zephir H, Kwiatkowski A, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Laplaud DA, Berger E, Dubessy AL, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al-Khedr A, Casez O, Bourre B, Wahab A, Magy L, Moulin S, Camdessanché JP, Doghri I, Sarov-Riviere M, Hankiewicz K, Pottier C, Dos Santos A, Nifle C, Subtil F, Vukusic S; OFSEP Investigators. Gavoille A, et al. JAMA Neurol. 2025 Oct 1;82(10):994-1003. doi: 10.1001/jamaneurol.2025.2550. JAMA Neurol. 2025. PMID: 40758347